Representative before the EPO

Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
1106.03
Headquarter in Cleveland and 38 offices
active in Legal Services

Martin Weber has worked on the following 15 EPO patent applications which have been published in the last five years:

EP11701732

TREATMENT OF BONE-RELATED CANCERS USING PLACENTAL STEM CELLS

IPC classification:
C12N 5/074, C12N 5/0775
Applicant:
Anthrogenesis Corp
Agent:
Martin Weber, Jones Day
Status:
The patent has been granted
EP11769676

ANTI-BACTERIAL APPLICATIONS OF POLY -N-ACETYLGLUCOSAMINE NANOFIBERS

IPC classification:
A61K 9/00, A61K 31/70, A61K 31/7008, A61K 31/715, A61K 33/00, A61K 36/02, A61K 45/06, A61P 31/00, A61P 31/04
Agent:
Martin Weber, Jones Day
Status:
EXAMINATION REQUESTED
EP10805335

PHOSPHATIDYLINOSITOL-3-KINASE PATHWAY BIOMARKERS

IPC classification:
C12Q 1/68
Applicant:
Wyeth LLC
Agent:
Martin Weber, Jones Day
Status:
EXAMINATION IN PROGRESS
EP12774049

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROMYELITIS OPTICA

IPC classification:
A61K 39/00, A61P 25/00
Applicant:
The Regents of the University of Colorado
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Agent:
Martin Weber, Jones Day
Status:
GRANT OF PATENT INTENDED
EP13182315

Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

IPC classification:
A61K 31/4035
Applicant:
Celgene Corporation
Agent:
Martin Weber, Jones Day
Status:
GRANT OF PATENT INTENDED
EP13182313

Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

IPC classification:
A61K 31/4035
Applicant:
Celgene Corporation
Agent:
Martin Weber, Jones Day
Status:
GRANT OF PATENT INTENDED
EP12796395

COMPOUNDS AND COMPOSITIONS FOR STABILIZING HYPOXIA INDUCIBLE FACTOR-2 ALPHA AS A METHOD FOR TREATING CANCER

IPC classification:
A61K 31/195, A61K 31/4412, A61P 35/00, C07D 213/81
Agent:
Martin Weber, Jones Day
Agent:
Hoefer & Partner
Status:
GRANT OF PATENT INTENDED
EP11775542

MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF PROPYLENE

IPC classification:
C12P 5/02
Applicant:
Genomatica, Inc.
Agent:
Martin Weber, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11810776

ENHANCEMENT OF PLACENTAL STEM CELL POTENCY USING MODULATORY RNA MOLECULES

IPC classification:
A61K 31/7088, A61K 35/50, A61P 37/06, C12N 5/073, C12N 15/113
Applicant:
Anthrogenesis Corp
Agent:
Martin Weber, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10836412

METHODS AND ORGANISMS FOR CONVERTING SYNTHESIS GAS OR OTHER GASEOUS CARBON SOURCES AND METHANOL TO 1,3-BUTANEDIOL

IPC classification:
C12N 1/20, C12P 7/52
Applicant:
Genomatica, Inc.
Agent:
Martin Weber, Jones Day
Status:
APPLICATION WITHDRAWN
EP11792867

COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES

IPC classification:
A61K 9/14, A61K 31/16, A61K 31/337, A61K 31/7068, A61K 45/06, A61P 35/00
Agent:
Martin Weber, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11737470

MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF P-TOLUATE AND TEREPHTHALATE

IPC classification:
C12N 9/00
Applicant:
Genomatica, Inc.
Agent:
Martin Weber, Jones Day
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11736605

NEUREGULIN BASED COMPOSITIONS AND USES THEREOF FOR PREVENTING OR TREATING MYOCARDIAL ISCHEMIA-REPERFUSION INJURY

IPC classification:
A61K 38/18, A61P 9/10
Agent:
Martin Weber, Jones Day
Status:
GRANT OF PATENT INTENDED
EP11702567

METHODS OF IN SITU DETECTION OF NUCLEIC ACIDS

IPC classification:
C12Q 1/68
Agent:
Martin Weber, Jones Day
Status:
EXAMINATION IN PROGRESS
EP15757753

IMPROVED REPROGRAMMING METHODS AND CELL CULTURE PLATFORMS

IPC classification:
C12N 5/074
Agent:
Martin Weber, Jones Day
Agent:
Cooley (UK) LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature